A novel specific peroxisome proliferator‐activated receptor γ (PPARγ) modulator YR4‐42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet‐induced obese mice

AIMS: To evaluate a novel tetrahydroisoquinoline derivative YR4‐42 as a selective peroxisome proliferator‐activated receptor γ (PPARγ) modulator (SPPARM) and explore its anti‐diabetic effects in vitro and in vivo. MATERIALS AND METHODS: Using two standard full PPARγ agonists rosiglitazone and piogli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Huan, Yi, Pan, Xuan, Peng, Jun, Jia, Chunming, Sun, Sujuan, Bai, Guoliang, Wang, Xing, Zhou, Tian, Li, Rongcui, Liu, Shuainan, Li, Caina, Liu, Quan, Liu, Zhanzhu, Shen, Zhufang
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6851555/
https://ncbi.nlm.nih.gov/pubmed/31364797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13843
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados